Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Assessing the feasibility and acceptability of a cluster-randomized study of cognitive behavioral therapy for chronic insomnia in a primary care setting

BMC Family Practice volume 22, Article number: 77 (2021) Cite this article

Abstract

Background

Cognitive behavioral therapy for chronic insomnia (CBT-i) is the treatment of choice for this condition but is underutilized in patients who attend primary care. The purpose of the present feasibility-pilot study was to assess the feasibility and acceptability of a cluster-randomized study of CBT-i in a primary care setting.

Methods

This study, performed at two primary health care centers in Majorca, Spain, was a mixed methods feasibility-pilot study of a parallel cluster-randomized design comparing CBT-i and usual care (UC). Patients were included if they were 18 to 65 years-old; had diagnoses of chronic insomnia according to the Insomnia Severity Index (ISI ≥ 8); had insomnia for more than 3 months. Twenty-five GPs and nurses and 32 patients were randomly allocated to two groups. The main outcome of the intervention was improvement of dimensions of sleep quality, measured using the Spanish version of the Pittsburgh Sleep Quality Index, at baseline and at 3 months after the intervention. Other primary outcomes of the study were the feasibility and applicability of the intervention, collected through nominal groups. A thematic analysis was performed to classify primary care provider (PCP) proposals. Additionally, we assessed the recruitment process, compliance with the intervention sessions, and patient retention.

Results

We adapted the CBT-i approach of Morin to a primary care context. After intervention training, PCPs expressed the need for more extensive training in the different aspects of the therapy and the discussion of more cases. PCPs considered the intervention as adequate but wanted fewer but longer sessions as well as to discard the cognitive restructuring component. PCPs considered it crucial to prepare each session in advance and to establish a specific agenda for the CBT-i. Regular reminders given to PCPs and patients were suggested to improve study participation. Compared to the UC group, higher proportions of patients in the intervention group had short sleep latency, slept for longer than 5 h, and had fewer sleep disruptions.

Conclusions

This feasibility-pilot study identified several key issues that must be addressed before performing a CBT-i intervention in future clinical trial in a primary care setting.

Trial registration

NCT04565223. (Clinical trials.gov) Registered 1 September 2020—Retrospectively registered.

Peer Review reports

Background

Insomnia is a disorder characterized by difficulties in falling asleep and staying asleep during the night or the perception of having a non-restful sleep [1]. It is the most common sleep disorder in the general population, affecting 6.4% of people in Spain. Moreover, 20.8% of individuals in Spain experience symptoms of insomnia at least 2 or 3 times per week [2, 3]. Even higher percentages have been reported for other European countries [4,5,6,7]. Chronic insomnia is a significant burden to society because it can lead to the development of physical [8, 9] and psychological disorders, increase the risk of road accidents [10, 11], and lead to excessive sick leave [9] and greater use of health care services [12, 13].

In spite of its high prevalence and association with multiple health problems, there is only limited availability of effective treatments for insomnia. Hypnotic medications (i.e., benzodiazepines and/or Z drugs) often effectively alleviate symptoms, but can lead to side-effects, dependency, and tolerance [14, 15]. Cognitive behavioral therapy for insomnia (CBT-i) is a multicomponent intervention which focuses on cognitive and behavioral factors that contribute to sleep disorders [16]. Recent systematic reviews showed that CBT-i provided by psychologists and psychiatrists is more effective than usual treatments [17] and medications, and also lasts longer [18], even in patients with comorbidities [19].

However, the efficacy of CBT-i when applied by general practitioners (GPs) or primary care (PC) nurses has not been sufficiently demonstrated. A study that compared CBT-i provided by PC nurses with usual care provided by a GP indicated that CBT-i was associated with improvements in self-reported sleep latency, wakefulness after sleep onset, and sleep efficiency, and that patients receiving usual care did not improve [20]. Another study of CBT-i provided by PC nurses [21] also showed that this intervention provided distinct reductions in night awakening and sleep latency.

CBT-i is underutilized by GPs and PC nurses for several reasons. These include the following: (1) CBT-i is not designed for use by primary care providers (PCPs) [22], (2) it requires significant effort to motivate patients to change their behaviors [23], (3) it can be very time-consuming; (4) PCPs typically lack the skills to administer CBT-i; and (5) many PCPs do not consider insomnia to be an important issue [24, 25]. However, most patients with insomnia are diagnosed in PC settings [26]. Thus it is necessary to have an effective CBT-i that is adapted to the skills of PCPs, because implementation of therapy in this setting may have a greater impact.

In the present work, we performed a mixture of a feasibility study and a pilot study of the effectiveness of a CBT-i intervention in PC patients with insomnia. This study examined many of the procedures to be used in a future trial in an effort to prevent problems during this upcoming trial [27].

Objectives

The primary objectives of this feasibility-pilot study were:

  1. 1.

    To design and adapt a brief CBT-i intervention to be provided by PCPs for the treatment of chronic insomnia in individuals who are 18 to 65 years-old.

  2. 2.

    To define usual care (UC) for the treatment of chronic insomnia provided by PCPs as a comparative intervention (control group).

  3. 3.

    To assess the training activities for the CBT-i intervention by determining GPs’ and nurses’ satisfaction with the content and applicability of the intervention.

  4. 4.

    To explore the acceptability of the intervention to GPs and nurses.

  5. 5.

    To assess PCPs and patient recruitment, follow-up, and adherence to the intervention.

The secondary objective was to assess the quality of sleep in patients after 3 months of the CBT-i.

Methods

Design

This was a mixed-methods feasibility-pilot study of a two-arm cluster-randomized trial comparing CBT-i and usual care (UC). The allocated groups were PC doctors and nurses (the clusters). The study was performed from September 2014 to April 2015 at two primary health care centers of Majorca (Spain) with 56,000 registered inhabitants. This study adheres to CONSORT guidelines.

Intervention

CBT-i Intervention

The CBT-i intervention was developed by two family physicians (IT and CV) and two psychologists (ET and MRPP). First, a review of the literature on the use of CBT-i was performed, with a focus on interventions applied in a PC setting. After a literature review, the CBT-i approach designed by Morin [16] was adapted to our setting, in which there were fewer and shorter sessions. The CBT-i included sleep hygiene counseling, stimulus control, cognitive restructuring, relaxation techniques, and benzodiazepine withdrawal (when needed). To conduct the intervention, guidelines for GPs and nurses and graphic and written materials for patients (sleep diary, registry of behavior habits, and cognitive problems) were developed.

Description of the intervention

We developed the CBT-i program for implementation by PC family doctors and nurses. The intervention requires active participation of patients for the treatment of insomnia. There were 5 individual sessions of approximately 20 min each, with one session per week or every 2 weeks (based on patient preference) and an additional session for patients undergoing withdrawal of hypnotic medications [28]. Table 1 describes the content of each session.

Table 1 Summary of the intervention sessions
Full size table

This intervention aims to change the habits of the affected patients, and to encourage them to undergo a cognitive and physical deactivation before going to sleep. It aims to help patients to identify and assess how they react before, during, and after sleep and to consider thoughts and behaviors that contribute to insomnia (Behavior-Problem) with the help of a sleep diary. The intervention offers patients a wide range of structured strategies, based on their possible impact (Behavior-Goal). The patient and therapist agreed on the therapeutic objectives before commencement of treatment. These objectives determine the content of the intervention sessions. After each session, patients have a task to work on at home, in which they try to achieve different goals and use different techniques. During treatment, the therapist was available to address doubts and difficulties that the patients may experience. Therapists were asked to record any relevant information from patients that arose during the intervention sessions.

The sleep diary contains a 2-week registry that records the following data: sleeping hours, sleep latency, duration of awakening and number of awakenings, number of times getting out of bed, naps, medication use, and sleep quality. Patients also identified the main difficulties they experienced during the night and reported desired objectives and how they can be achieved.

We developed the CBT-i program for implementation by PC family doctors and nurses. The intervention requires active participation of patients for the treatment of insomnia. There were 5 individual sessions of approximately 20 min each, with one session per week or every 2 weeks (based on patient preference) and an additional session for patients undergoing withdrawal of hypnotic medications [28]. Table 1 describes the content of each session.

This intervention aims to change the habits of the affected patients, and to encourage them to undergo a cognitive and physical deactivation before going to sleep. It aims to help patients to identify and assess how they react before, during, and after sleep and to consider thoughts and behaviors that contribute to insomnia (Behavior-Problem) with the help of a sleep diary. The intervention offers patients a wide range of structured strategies, based on their possible impact (Behavior-Goal). The patient and therapist agreed on the therapeutic objectives before commencement of treatment. These objectives determine the content of the intervention sessions. After each session, patients have a task to work on at home, in which they try to achieve different goals and use different techniques. During treatment, the therapist was available to address doubts and difficulties that the patients may experience. Therapists were asked to record any relevant information from patients that arose during the intervention sessions.

The sleep diary contains a 2-week registry that records the following data: sleeping hours, sleep latency, duration of awakening and number of awakenings, number of times getting out of bed, naps, medication use, and sleep quality. Patients also identified the main difficulties they experienced during the night and reported desired objectives and how they can be achieved.

Description of usual care

The usual treatment for persistent insomnia in a PC setting was previously described in two cross-sectional studies performed by GPs and family nurses of the Primary Care Majorca Department (Spain) during 2011 and 2015 [29, 30].

The professionals in the control group followed their usual care in treatment of insomnia patients. A previous descriptive study of insomnia treatments used by GPs in Majorca from 2001 to 2012 indicated that more than 95% of them asked patients about habits related to sleep hygiene that might lead to insomnia, 85.1% provided to advice on sleep hygiene measures, 15.1% suggested the use of herbal remedies, and 14.2% suggested CBT-i. More than 33% of GPs prescribed a pharmacological treatment. Benzodiazepines were the most prescribed drugs (33.4%) followed by Z drugs (25.7%). Six of 10 GPs requested a review of the treatment after 1 month of medication use [29].

The usual care provided by nurses was based on a 2014 descriptive study (performed simultaneously with the present study). This study reported that 69.6% of nurses asked patients about their sleeping habits and 48.5% asked about the consequences of their insomnia. A total of 46.4% considered pharmacological interactions and 45.6% gave special consideration to elderly patients. The non-pharmacological treatments they recommended were sleep hygiene measures (76%), herbal remedies (44.9%), and CBT-i (22.4%). About 25% of nurses offered written advice and 81% gave oral advice on sleep hygiene [30].

Subject recruitment

Sixteen GPs and 7 nurses, who expressed interest in the study, after study presentation in the two health centers, were recruited in September 2014. They were each given a list of 6 patients with chronic insomnia, and each of them selected 2 patients from the list who were eligible. Patients with chronic insomnia who visited their GPs or family nurses could also be recruited. Patients were included if they were 18 to 65 years-old; had diagnoses of chronic insomnia according to the Insomnia Severity Index (ISI ≥ 8) [31, 32] and had insomnia longer than 3 months; and did or did not use a hypnotic medication. Patients were excluded if any of the following conditions were present: secondary insomnia or another sleep disorder, such as restless legs syndrome, parasomnia, or alterations of the circadian rhythm (e.g., due to shift work), or use of a medication that could produce sleep alterations; severe psychiatric disorder; depression (HADS score ≥ 8) or diagnosis of major depression in the clinical records; suicide attempt; use of an antidepressant or anti-psychotic medication; alcohol or drug abuse during the last year; receipt of another CBT-i; chronic disease, such as sleep apnea; diagnosis of dementia or presence of a cognitive deficit (Mini Mental State Evaluation (MME) score < 23); neurodegenerative or oncological disease with poor prognosis; mental or physical incapacities that impeded participation in interviews [33, 34]; acute or chronic pain secondary to a rheumatic disease or another untreated chronic disease; pregnancy; or participation in a previous clinical trial in the participating health centers.

Patients were invited to participate personally or by telephone. If a patient agreed, an appointment in the health care center was scheduled, at which they received oral and written information about the study. If a patient was accepted and deemed eligible, he or she completed the ISI questionnaire to confirm the presence of chronic insomnia, signed an informed consent agreement, and received an appointment for a baseline evaluation.

Group allocations and blinding

GPs and nurses were randomized (1:1) to the CBT-i intervention group (IG) or the usual care group (UCG) using computer generated random numbers by the Research Unit study manager. PCPs were allocated in the IG after they had selected at least two patients from their list. Two GPs from the research team (CV, and IT) were allocated to the IG because they had the expertise to provide thorough and accurate information about the implementation of the intervention and the need for further training. The two psychologists (ET and MRP-P) delivered the intervention to one patient each in order to share with PCPs which aspects of the intervention could be improved. Blinding of patients and clinicians was not possible due to the nature of the intervention; the assistant researcher was also not blinded, because this person conducted interviews at 3 months that included treatment-specific questions. The objectives of this feasibility-pilot study were focused on assessing clinical trial processes, not on patient outcomes.

Measurements

Feasibility dimensions

The primary measures were: assessment of the acceptability of the training to PCPs (satisfaction with the content, applicability, and ability to provide sufficient training); feasibility of the designed intervention for administration by trained GPs and nurses; and feasibility of the study design (recruitment, follow up, and retention).

CBT-i training

All doctors and nurses were trained on data collection procedures and administration of questionnaires and psychometric scales. Then, those who were allocated to the intervention group received training in CBT-i from the two psychologists (ET and MRPP). This training (2 sessions, 2 h per session) explained the content of the planned intervention and presented a case report. After the training sessions, a focus group session was conducted in which one investigator (ME), using a script containing questions on the different dimensions, collected the opinions of the doctors and nurses regarding the adequacy, content, and duration of their training, and asked for their ideas about possible improvements.

Acceptability of the intervention by GPs and nurses

To assess acceptance of the intervention by PCPs, two nominal groups were established, one in each health center. These nominal groups conducted discussions run by one member of the research group (ME) and supported by one observer (MCVT). The group discussions were designed to follow the nominal group process [35] regarding the introduction and clarification of the research task; individual generation of ideas; generation of ideas as a group (proposing ideas for recording on a flip chart); refining the list of ideas by adding, merging, or removing certain ideas; individually ranking the five most important ideas; and then a group review of the aggregate ranking of ideas. The introduction included obtaining consent from all participants. The observer tasks included assuring that all topics in the script were considered during nominal group development. A thematic analysis was undertaken with the aim of identifying the main themes generated during the nominal group’s discussions.

Pilot study measurements

The variables used to assess the potential effectiveness of the intervention were measured at baseline interview and at 3 months post-treatment; they included the validated Spanish version of the Pittsburgh Sleep Quality Index (PSQI) [36, 37]; the Spanish version of Hospital Anxiety and Depression Scale (HADS) [38, 39]; and use of hypnotic medications. The PSQI is a 19-item self-reported questionnaire that assesses 7 clinical relevant components of sleep quality (subjective sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, use of sleep medication and daytime dysfunction) in the preceding month. Each component is rated on 0 to 3 point scale referring to the composite score derived from the frequencies of each disturbance, in which 0 corresponds to not in the past month and 3 corresponds to 3 or more times per week, with a global score (the sum of the 7 component scores) ranging from 0 to 21. A cut off score of 5 has been shown to discriminate between good and poor sleepers [36, 37].

The HADS measures anxiety and depression levels. It is a 14-item self-report scale with a 7-item anxiety subscale and a 7-item depression subscale. Each item is scored on a 4-point Likert scale (e.g., 0, as much as I always do; 1, not quite so much; 2, definitely not so much; and 3, not at all), giving maximum subscale scores of 21 for each of depression and anxiety. The questionnaire assesses symptoms over the preceding week. Patients with scores > 10 are considered to have morbidity. Scores between 8 and 10 were considered as borderline cases and scores < 8 were considered to indicate the absence of relevant morbidity [38, 39]. Use of hypnotic medications was also recorded, as reported by patients and verified from clinical records.

In addition, adverse effects at 3 months after the intervention that could be associated with the CBT-i or benzodiazepine discontinuation (tremor, irritability, anxiety, insomnia, and seizure) were recorded, and their severities were rated as none, mild, moderate, or severe. Therapists were asked to report any serious adverse events during the follow-up period to the research coordinator.

The independent variables were group allocation; socio demographic characteristics (sex, age, level of education, and marital status); and co-morbidities.

Patient recruitment, follow-up, and adherence to the intervention

To assess the patient recruitment process, study acceptance, and adherence to the intervention, the numbers of patients who were initially contacted, who agreed to participate, who were lost to follow-up, and who received a final evaluation were recorded.

Statistical analysis

All statistical analyses were carried out on an intention-to-treat basis using SPSS v.23. To assess the effect of CBT-i at 3 months in the measurement of quality of sleep, HADS depression score, HADS anxiety score, and changes in hypnotics and antidepressant use, between groups chi square tests were used with a confidence level of 95%. As the sample size was very small, the likelihood ratio test for contingency tables was used for comparisons where the expected frequencies were less than 5. Confidence intervals at 95% were also calculated.

This study received approval from the Majorca Primary Care Research Committee (Nº PI14-19).

Results

Acceptability and assessment of the training

PCPs assessed the training they received regarding the intervention during a foucs group conducted by ME. This group consisted of 12 doctors (6 in the IG and 6 in the UCG), 3 nurses (2 in the IG and 1 in the UCG). Also, the 2 psychologists participated in the group discussion. This group’s assessment of the training had several general conclusions:

  • The training sessions should be longer, more practical advice should be given, and there should be more discussion of different cases.

  • There is a need to provide a theoretical context for CBT-i.

  • The different components of the therapy (sleep diary, identification of sleep problems, stimulus control, and relaxation) need more complete coverage.

  • There is a need for more training on how to teach patients to restructure their thoughts and develop the ability to achieve concrete goals.

  • The case reports described during the training sessions generated extensive input, and was considered important in clarification of some key concepts.

Acceptability and assessment of the intervention

Regarding the recruitment of patients, both groups highlighted the difficulty in identification of eligible patients with chronic insomnia, and that most patients with insomnia symptoms had other mental disorders. GPs and nurses suggested use of no age limit, increasing the ISI cut-off to 14, and consideration of clinical assessments (i.e., poor quality of life). Also, participants in the nominal groups suggested that apart from personal invitations by PCPs, invitation posters should be installed throughout the health center and in the community. All professionals agreed that time constraints were a problem for some patients. Table 2 summarizes the positive and negative aspects of the intervention in the nominal groups.

Table 2 Positive aspects and difficulties of the intervention that were reported in both nominal groups or only in one nominal group
Full size table

Assessment of the recruitment process and study acceptance

Figure 1 summarizes our assessment of the recruitment process and study acceptance by PCPs and patients. After study presentation in the two health centers, 25 PCPs agreed to participate (15 in the IG and 10 in the UCG). Four PCPs in each group did not recruit any eligible patients. Thus, 32 patients were recruited, 19 in the IG and 13 in the UCG. Two patients were lost to follow-up in the IG and 2 were lost to follow-up in the UCG.

Fig. 1
figure 1

PCP participants and recruitment of patients (CONSORT flow diagram)

Full size image

Effect of the intervention

Table 3 shows the socio demographic characteristics of the IG and UCG groups of patients. The most notable differences were that the IG had fewer married patients and fewer patients with university level education.

Table 3 Baseline sociodemographic characteristics and ISI scores in the intervention group (n = 19) and control group (n = 13)
Full size table

Table 4 shows the effects of the intervention in the two groups. The proportion of patients with short sleep latency (0–4 min) was higher in the IG (82.4%, 95%CI 56.5–96.2) than in the UCG (45.5%, 95%CI 16.7%-76.6%). In addition, higher proportions of patients in the IG group slept for longer than 5 h, 68.8% (95%CI 41.3–88.9) vs. 11.1% (95%CI 0.2%-48.2%) and had fewer sleep disruptions 88.2% (95%CI 63.5–98.5) vs. 54.5% (95%CI 23.4–83.2). Due to small numbers in each group, these differences could not be taken into account to draw any conclusions. No differences between groups were found for depression, anxiety or hypnotic use or changes in hypnotic and antidepressant drugs.

Table 4 PSQI results, HADS results, and use of hypnotics and anti-depressants after 3 months in the intervention group (n = 19) and the control group (n = 13)
Full size table

Assessing the adherence to intervention

Five of the 19 patients in the IG did not complete all the scheduled sessions (1 attended no sessions, 1 attended one session, 2 attended two sessions, and 1 attended 3 sessions). The other 14 attended the entire schedule of 5 sessions, with a benzodiazepine withdrawal session if needed.

Discussion

Pilot and feasibility studies play an invaluable part in health research. The results of pilot studies allow the research team to reconsider the procedures and design of the subsequent main study. The present study provided us with important information about several fundamental issues that must be addressed before beginning a large trial to assess the effectiveness of a CBT-i intervention implemented by PC doctors and nurses in patients with persistent insomnia [28, 40, 41]. The following changes are suggested.

Intervention

The present study provided 5 sessions of CBT-i and an extra session for benzodiazepine withdrawal (if necessary). We evaluated the acceptability of this intervention using the nominal group technique to obtain opinions from the PCPs. They considered the format of the intervention as adequate, but PCPs and patients advocated the use of fewer sessions and to redesign the content of the CBT-i, by removing cognitive restructuring component because PCPs do not feel comfortable with this aspect of the intervention. Also, PCPs advocated the use of an “Intervention Guide” for PCPs as a key element, and also providing written materials for patients. They suggested that the materials for patients should cover topics such as instructions for keeping a sleep diary and a guideline for sleep hygiene, stimulus control, and control of thoughts that contribute to insomnia, and that these materials should be adapted for patients with little education. The PCPs also recommended implementation of some changes in the intervention. In particular, they considered it crucial for PCPs to make certain preparations prior to each CBT-i session, establish a specific agenda, and schedule sessions at times that are less tiring for the PCP and also consider patient availability.

Training in CBT-i

We also identified the need to improve the training of PCPs by use of a longer training program and providing more presentations of cases that experience chronic insomnia. Thus, in the subsequent large trial, we will include some PCP suggestions about certain aspects of the training, such as to provide a more thorough discussion of the different components of therapy, to negotiate with patients the objectives of each session, and to instigate a more active follow-up of PCPs by use of periodic phone calls.

Results of the intervention

Although this study was not designed to test a hypothesis, it showed improvements in three dimensions of the PQSI. That is, IG patients appeared to benefit from the intervention in terms of decreased sleep latency, increased sleep duration, and decreased sleep disruptions. However, we cannot place great weight on these results, because no formal sample calculations were performed and there may have been imbalances in the pre-randomization covariates. Moreover, this was an external pilot study, and the patients recruited in this work will not be included in the subsequent large study [27].

Recruitment and follow-up of participants and patients

We had difficulties in getting doctors and nurses to participate in this trial, and some of the participants did not include any patients. In our subsequent large study, it will be necessary to work with PCPs in the recruitment of patients and implementation of the intervention. Not all PCPs have the skills to learn the basics of CBT-i, so a more careful selection of doctors and nurses should be performed in the subsequent trial.

Additionally, we found that the recruitment of patients was difficult. We therefore plan to improve the recruitment process by use of poster invitations in health centers and in the community. Furthermore, as the PCPs proposed, we will adjust the eligibility for participation in subsequent large trial. To increase patient adherence to treatment, patients will be included if they present with more severe insomnia (ISI > 14) and have poorer sleep quality. The use of more stringent criteria could increase patient motivation to participate and these patients also have greater potential for improvement. Also, reminders to PCPs and patients will be used to increase the participation.

Pilot and feasibility studies play an invaluable part of health research. We tried to be explicit as possible about the purpose of this pilot study, as proposed by Lancaster and by Arain [40, 42]. Methodological rigor is achieved by using a well-conceived and well-designed study that has clear aims and objectives, and uses a high quality definitive randomized and controlled design.

Limitations

One of the main limitations of the study was the lack of patient involvement in the research process. We originally planned to assess patients’ opinions about the intervention, but the study ended during the summer and the residents left to work in hospitals or other health centers and could not perform this task. Fortunately, the participating PCPs reported feedback from some their patients’ comments during the nominal groups, and we will consider these comments prior to the subsequent large trial.

This study had some characteristics of a feasibility study, in that we used focus group and nominal group techniques to determine if a subsequent large trial would be feasible and reproducible. On the other hand, this study also had some characteristics of a pilot study, in that we focused on the processes to be used in a large RCT, such as recruitment, randomization, treatment, and follow-up, to identify problems that might occur in the subsequent large study.

Conclusions

This external pilot-feasibility study indicated the need to address several key issues before performing the subsequent large clinical trial. Additional and longer training of PCPs is needed to ensure that they have sufficient skills to implement CBT-i intervention. In particular, PCPs should receive more training in cognitive therapy and increase the number of case presentations in order to gain skills in managing different possible situations. Also, in the large study, higher numbers of patients with more severe insomnia and poor quality of sleep should be invited to participate, and greater flexibility should be used to fit with the times they can attend CBT-i sessions. In addition, this preliminary work highlighted the need to adapt PCPs’ work schedules to deliver the intervention with longer and previously prepared sessions. The reporting of these practical issues in this pilot study will help to prevent similar pitfalls and mistakes in the subsequent large trial.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. PCPs and patients material guides for CBT-i are available in the following links: https://zenodo.org/record/4629880#.YFsyXVVKiUk and https://zenodo.org/record/4629814#.YFswu1VKiUk.

Abbreviations

CBT-i:

Cognitive behavioral therapy for chronic insomnia

IG:

Intervention group

CG:

Control group

HADS:

Hospital anxiety and depression scale

ISI:

Insomnia Severity Index

MME:

Mini Mental State Evaluation

PC:

Primary care

PCPs:

Primary care professionals

PSQI:

Pittsburg Sleep Quality Index

UC:

Usual care

UCG:

Usual care group

References

  1. Caballo VE, Salazar IC, Carrobles JA. Manual de Psicopatología y Trastornos Psicológicos. 2on ed. Madrid: Ediciones Pirámide; 2014.

    Google Scholar 

  2. Ohayon MM, Sagales T. Prevalence of insomnia in the general population of Spain. Sleep Med. 2010. https://doi.org/10.1016/j.sleep.2010.02.018.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Torrens I, Argüelles-Vazquez R, Lorente-Montalvo P, Molero-Alfonso C, Esteva M. Prevalence of insomnia and characteristic of patients with insomnia in a health area of Majorca (Spain). Aten Primaria. 2019. https://doi.org/10.1016/j.aprim.2018.02.014.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia:distinguishing beteween insomnia related mental disorder from sleep disorders. J Psychiatr Res. 1997. https://doi.org/10.1016/s0022-3956(97)00002-2.

    Article  PubMed  Google Scholar 

  5. Ohayon MM, Zuley J. Correlates of global sleep dissatisfaction in German population. Sleep. 2001;12:295–306.

    Google Scholar 

  6. Ohayon MM, Smirne S. Prevalence and consequences of insomnia disorders in the general population of Italy. Sleep Med. 2002. https://doi.org/10.1016/s1389-9457(01)00158-7.

    Article  PubMed  Google Scholar 

  7. Ohayon MM, Caulet M, Priest RG, Guilleminault C. DSM-IV abd UCSD-90Insomnia symptoms and sleep dissatisfaction. Br J Psychiatry. 1997. https://doi.org/10.1192/bjp.171.4.382.

    Article  PubMed  Google Scholar 

  8. St-Onge MP, Grandner MA, Brown D, Conroy MB, Jean-Louis G, Coons M, Bhatt DL, American Heart Association Obesity, Behavior Change, Diabetes, and Nutrition Committees of the Council on Lifestyle and Cardiometabolic Health, Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Stroke Council. Sleep duration and quality: impact on lifestyle behaviors and cardiometabolic health: a scientific statement from the American Heart Association. Circulation. 2016. https://doi.org/10.1161/CIR.0000000000000444.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Lavie P. Sleep habits and sleep disturbances in industrial workers in Israel: main findings and some characteristics of workers complaining of excessive daytime sleepiness. Sleep. 1981. https://doi.org/10.1093/sleep/4.2.147.

    Article  PubMed  Google Scholar 

  10. Léger D, Partinen M, Hirshkowitz M, Chokroverty S, Touchette E, Hedner J, EQUINOX. Daytime consequences of insomnia symptoms among outpatients in primary care practice: EQUINOX international survey. Sleep Med. 2010; doi: https://doi.org/10.1016/j.sleep.2010.04.018.

  11. Sagberg F. Driver health and crash involvement: a case-control study. Accid Anal Prev. 2006. https://doi.org/10.1016/j.aap.2005.06.018.

    Article  PubMed  Google Scholar 

  12. Daley M, Morin CM, LeBlanc M, Grégoire JP, Savard J. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers. Sleep. 2009;32:55–64.

    Article  Google Scholar 

  13. Wickwire EM, Shaya FT, Scharf SM. Health economics of insomnia treatments: the return on investment for a good night’s sleep. Sleep Med Rev. 2016. https://doi.org/10.1016/j.smrv.2015.11.004.

    Article  PubMed  Google Scholar 

  14. Glass J, Lanctôt KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis. BMJ. 2005. https://doi.org/10.1136/bmj.38623.768588.47.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 2000;162:225–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Morin CM. Insomnia: psychological assessment and management. New York: Guildford Press; 1993.

    Google Scholar 

  17. Mitchell MD, Gehrman P, Perlis M, Umscheid CA. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012. https://doi.org/10.1186/1471-2296-13-40.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002. https://doi.org/10.1176/appi.ajp.159.1.5.

    Article  PubMed  Google Scholar 

  19. Geiger-Brown JM, Rogers VE, Liu W, Ludeman EM, Downton KD, Diaz-Abad M. Cognitive behavioral therapy in persons with comorbid insomnia: a meta-analysis. Sleep Med Rev. 2015. https://doi.org/10.1016/j.smrv.2014.11.007.

    Article  PubMed  Google Scholar 

  20. Bothelius K, Kyhle K, Espie CA, Broman JE. Manual-guided cognitive-behavioural therapy for insomnia delivered by ordinary primary care personnel in general medical practice: a randomized controlled effectiveness trial. J Sleep Res. 2013. https://doi.org/10.1111/jsr.12067.

    Article  PubMed  Google Scholar 

  21. Espie CA, MacMahon KM, Kelly HL, Broofield NM, Douglas NJ, Engleman HM, et al. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep. 2007. https://doi.org/10.1093/sleep/30.5.574.

    Article  PubMed  Google Scholar 

  22. Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, et al. An American academy of sleep medicine report. Practice parameters for the psychological and behavioral treatment of insomnia: an update. Sleep. 2006;29:1415–9.

  23. Bluestein D, Healey AC, Rutledge CM. Acceptability of behavioral treatments for insomnia. J Am Board Fam Med. 2011. https://doi.org/10.3122/jabfm.2011.04.110108.

    Article  PubMed  Google Scholar 

  24. Griffiths F, Lindenmeyer A, Powell J, Lowe P, Thorogood M. Why are health care interventions delivered over the internet? A systematic review of the published literature. J Med Internet Res. 2006. https://doi.org/10.2196/jmir.8.2.e10.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Perils ML, Smith MT. How can we make and other BSM services widely available? J Clin Sleep Med. 2008;4:11–3.

    Article  Google Scholar 

  26. Aikens JE, Rouse ME. Help-seeking for insomnia among adult patients in primary care. J Am Fam Med. 2005. https://doi.org/10.3122/jabfm.18.4.257.

    Article  Google Scholar 

  27. Shayinde M, Pickering RM, Weatherall M. Questions asked and answered in pilot and feasibility randomized controlled trials. BMC Med Res Methodol. 2011. https://doi.org/10.1186/1471-2288-11-117.

    Article  Google Scholar 

  28. Vicens C, Bejarano F, Sempere E, Mateu C, Fiol F, Socias I, Aragonès E, Palop V, Beltran JL, Piñol JL, Lera G, Folch S, Mengual M, Basora J, Esteva M, Llobera J, Roca M, Gili M, Leiva A. Comparative efficacy of two interventions to discontinue long-term benzodiazepine use: cluster randomised controlled trial in primary care. Br J Psychiatry. 2014. https://doi.org/10.1192/bjp.bp.113.134650.

    Article  PubMed  Google Scholar 

  29. Torrens I, Ortuño M, Guerra JA, Esteva M, Lorente P. Actitudes ante el insomnio de los médicos de AP de Mallorca. Aten Primaria. 2016. https://doi.org/10.1016/j.aprim.2015.06.012.

    Article  PubMed  Google Scholar 

  30. Vidal-Thomàs MC, Yañez-Amorós B, Torrens I, Torres-Solera E, Esteva M. Conocimientos y actitudes de las enfermeras de Atención Primaria sobre el manejo del paciente con insomnio. Enferm Clin. 2017. https://doi.org/10.1016/j.enfcli.2016.11.006.

    Article  PubMed  Google Scholar 

  31. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001. https://doi.org/10.1016/s1389-9457(00)00065-4.

    Article  PubMed  Google Scholar 

  32. Sierra JC, Guillén-Serrano V, Santos-Iglesias P. [Insomnia Severity Index: some indicators about its reliability and validity on an older adult’s sample]. Rev Neurol. 2008;47:566–70.

    CAS  PubMed  Google Scholar 

  33. Rai GS. The mini-mental state examination. J Am Geriatr Soc. 1993. https://doi.org/10.1111/j.1532-5415.1993.tb06721.x.

    Article  PubMed  Google Scholar 

  34. Lobo A, Saz P, Marcos G, Día JL, de la Cámara C, Ventura T, Morales Asín F, Fernando Pascual L, Montañés JA, Aznar S. Revalidation and standardization of the cognition mini-exam (first Spanish version of the mini-mental status examination) in the general geriatric population. Med Clin (Barc). 1999;112:767–74.

    CAS  Google Scholar 

  35. Delbecq AL, Van der Ven AH. A group process model for problem identification and programme planning. J Appl Behav Sci. 1971;7:466–92.

    Article  Google Scholar 

  36. Buysse DJ. The Pittsburg Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989. https://doi.org/10.1016/0165-1781(89)90047-4.

    Article  PubMed  Google Scholar 

  37. Rico FM. Propiedades clinimétricas de la versión castellana del cuestionario de Pittsburg. Vigilia-Sueño. 1997;9:81–4.

    Google Scholar 

  38. Quintana JM, Padierna A, Esteban C, Arostegui I, Bilbao A, Ruiz I. Evaluation of the psychometric characteristics of the Spanish version of the hospital anxiety and depression scale. Acta Psychiatr Scand. 2003. https://doi.org/10.1034/j.1600-0447.2003.00062.x.

    Article  PubMed  Google Scholar 

  39. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x.

    Article  PubMed  Google Scholar 

  40. Lancaster GA, Dodd S, Willianson PR. Desing and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004. https://doi.org/10.1111/j.2002.384.doc.x.

    Article  PubMed  Google Scholar 

  41. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, Robson R, et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol. 2010. https://doi.org/10.1186/1471-2288-10-1.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Arain M, Capbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010. https://doi.org/10.1186/1471-2288-10-67.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge Carles Gil Ribes for assistance with reviewing the quality of databases and to Alfonso Leiva for his comments on the manuscript. The authors also thank Beatriz Yañez, Melany Puertas, Julio Olsen, Adriana Hemfelt, and Teresa Estrades for their contributions to the study.

Funding

This study was funded by annual grants of the Majorca Department of Primary Care (PI5/14) and from the Balearic College of Nursing (COIBA) grants number 568/14. This funding source had no role in the design of the study, nor did it have any role in its execution, analyses, interpretation of the data, or decision to submit results.

Author information

Authors and Affiliations

  1. Santa Ponsa Health Center, Majorca Department of Primary Care, Baleares Health Service [IbSalut], Riu Síl, 25, 07180, Santa Ponça, Majorca, Spain

    Isabel Torrens, María Rosa Pizá-Portell, Cristina Vidal-Ribas & Patricia Lorente-Montalvo

  2. Balearic Islands Health Research Institute (IdISBa), Edificio S, University Hospital Son Espases, Carretera de Valldemossa, 79, 07120, Palma, Majorca, Spain

    Isabel Torrens, Magdalena Esteva, Caterina Vicens & María Clara Vidal-Thomàs

  3. Primary Care Research Unit, Majorca Department of Primary Care, Baleares Health Service [IbSalut], Escola Graduada 3, 07001, Palma, Spain

    Magdalena Esteva, María Clara Vidal-Thomàs & Elena Torres-Solera

  4. Preventive Activities and Health Promotion Research Network (REDIAPP), Barcelona, Spain

    Magdalena Esteva, Caterina Vicens & María Clara Vidal-Thomàs

  5. Son Serra Health Center, Majorca Department of Primary Care, Baleares Health Service [IbSalut], Carrer de Matamusinos, 22, 07013, Palma, Majorca, Spain

    Caterina Vicens

Authors
  1. Isabel Torrens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Magdalena Esteva
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Caterina Vicens
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. María Rosa Pizá-Portell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. María Clara Vidal-Thomàs
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cristina Vidal-Ribas
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Patricia Lorente-Montalvo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Elena Torres-Solera
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The study was conceived by IT, ME and ET with support from PLM, CR and MCVT. The intervention was designed by IT, ET, RP and MCVT. ET and IT designed the materials for patients and primary care professionals. ET and ME jointly coordinated the study development and data collection. Nominal groups were organized and analyzed by MCVT and ME. ME conducted the quantitative analysis and wrote the first draft of the manuscript with additional comments from IT and ET. All authors read the manuscript thoroughly and approved the final version.

Corresponding author

Correspondence to Magdalena Esteva.

Ethics declarations

Ethics approval and consent to participate

All participants were informed about the study orally and with written information and provided written consent prior to being enrolled in the study. Ethical approval was granted by the Primary Care Research Committee of the Majorca Department of Primary Care, Balearic Health Service. Reference: PI14/019.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Torrens, I., Esteva, M., Vicens, C. et al. Assessing the feasibility and acceptability of a cluster-randomized study of cognitive behavioral therapy for chronic insomnia in a primary care setting. BMC Fam Pract 22, 77 (2021). https://doi.org/10.1186/s12875-021-01429-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12875-021-01429-5

Keywords

BMC Primary Care

ISSN: 2731-4553

Contact us